Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Pakuan Tbk. (UANG) Price & Performance

UBC Medical Indonesia Tbk.Trade
Pakuan Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Pakuan Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Pakuan Tbk. trades at Rp3,790 (market cap 4.97T, 1.84M 24h volume). The key difference: Pakuan Tbk. is far larger — about 7.2× UBC Medical Indonesia Tbk.'s market cap, and Pakuan Tbk. is more actively traded (1.84M versus 635.5K). Which is the better fit depends on your goals.

LABSUANG
Market Cap
691.25B4.97T
Volume
635.5K1.84M
Lot
6.36K18.41K
Turnover
110.15M7.06B
Average Price
173.333,833.97
Value
110.15M7.06B
Indicative Equilibrium Price
1743,790
Indicative Equilibrium Volume
50690

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
UANG
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Pakuan Tbk.

PT Pakuan Tbk (Company) was established based on the Deed No.21, dated March 08, 1971 of Ridwan Suselo, S.H., notary in Jakarta. The company began operations commercially since 1973

Read more on UANG